Identifying inherited endometrial cancer & the environmental and genetic factors
Identifying inherited endometrial cancer & the environmental and genetic factors
批准号:
7727350
负责人:
Paul Joseph Goodfellow
金额:
$12.7万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-09-18 至 2012-08-31
关键词:
AddressAdjuvant TherapyBody of uterusCancer BiologyCancer BurdenCancer PatientClinicalColon CarcinomaColonoscopyColorectalDNADNA Repair GeneDataDefectDetectionDiagnosisDiseaseDisease remissionEndometrialEndometrial CarcinomaEnvironmental Risk FactorEpidemiological FactorsEpigenetic ProcessExtended FamilyFamilyFamily history ofFamily memberFrequenciesGene SilencingGenesGeneticGynecologicGynecologic OncologistGynecologistHealth ProfessionalHereditary Nonpolyposis Colorectal NeoplasmsIncidenceIndividualInheritedInstructionLeadMLH1 geneMalignant Female Reproductive System NeoplasmMalignant NeoplasmsMethylationMismatch RepairMolecularMorbidity - disease rateMutationNested Case-Control StudyOvarianPatientsPredispositionPreventionRecurrent diseaseRelative (related person)Reproduction sporesRiskRisk AssessmentScreening procedureStagingSurvival RateSyndromeTreatment ProtocolsUnited StatesUterine CancerVariantWomanWorkepidemiologic datagene repairimprovedmolecular phenotypemortalitymutation carriernovel strategiesprobandpromotertumor
中文摘要
子宫内膜癌是美国最常见的妇科恶性肿瘤。大多数子宫内膜癌是
英文摘要
Endometrial cancer is the most common gynecologic malignancy In the US. Most endometrial cancers are
sporadic. However, some patients have an inherited cancer susceptibility, usually due to mutation in a DNA
mismatch repair gene. These women have Lynch syndrome. They are at much Increased risk for colorectal
and other malignancies, as are their family members.
Identification of endometrial cancer patients with Lynch syndrome is important to the proband and her family.
Intensified cancer surveillance is required for individuals with Lynch syndrome mutations. In particular,
colonic surveillance reduces cancer burden. Although health professionals are increasingly aware of Lynch
syndrome, most endometrial cancer probands with Lynch syndrome likely go undetected. Molecular
screening strategies should help to address this deficiency, but at present, the best approach is unknown.
The importance of DNA mismatch repair abnormalities in endometrial cancer is further evidenced by the high
frequency of acquired (somatic) defects, most frequently epigenetic silencing of the MLH1 repair gene. Our
group has shown inherited variation in the MLH1 gene itself is associated with risk for abnormal methylation
and gene silencing, and have data suggesting specific environmental factors contribute to risk. The aims for
this project address important questions regarding mismatch repair abnormalities in endometrial cancer.
(1) Develop of a molecular screening regimen to compliment family history risk assessment for the detection
of Lynch syndrome. >3,000 endometrial cancers from the GOG-210 study will be evaluated using MSI, IHC,
promoter methylation and gene sequencing. (2) Better estimate the frequency of Lynch syndrome among
endometrial cancer patients and determine the clinicopathologic significance of mismatch repair defects.
Detailed clinical, medical and family history and epidemiologic data from the GOG-210 study will be
correlated with molecular phenotypes. (3) Further refine the relationship between inherited variation in the
MLHI DNA repair gene and epigenetic silencing of MLHI in sporadic endometrial cancer. A nested case-
control study will define key genetic and environmental factor interactions. The work proposed will improve
identification of Lynch syndrome and with that reduce cancer burden, and better define key genetic and
environmental factor leading to somatic (acquired) inactivation of mismatch repair in endometrial cancers.
RELEVANCE (See instructions):
The work proposed will lead to both an improved understanding of endometrial cancer biology and new
approaches to the detection, prevention and treatment of uterine cancers which will result in reduced cancer
morbidity and mortality.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
COPY NUMBER VARIANTS AND EARLY-ONSET BREAST CANCER
-
批准号:8550773
-
项目类别:
-
资助金额:$33.3万
-
财政年份:2011
-
负责人:Paul Joseph Goodfellow
-
依托单位:
COPY NUMBER VARIANTS AND EARLY-ONSET BREAST CANCER
-
批准号:8328949
-
项目类别:
-
资助金额:$61.96万
-
财政年份:2011
-
负责人:Paul Joseph Goodfellow
-
依托单位:
COPY NUMBER VARIANTS AND EARLY-ONSET BREAST CANCER
-
批准号:8107328
-
项目类别:
-
资助金额:$62.14万
-
财政年份:2011
-
负责人:Paul Joseph Goodfellow
-
依托单位:
ATR Mutation in Endometrial Cancer
-
批准号:8549554
-
项目类别:
-
资助金额:$28.78万
-
财政年份:2011
-
负责人:Paul Joseph Goodfellow
-
依托单位:
ATR Mutation in Endometrial Cancer
-
批准号:8030053
-
项目类别:
-
资助金额:$30.82万
-
财政年份:2011
-
负责人:Paul Joseph Goodfellow
-
依托单位:
SPORE in Endometrial Cancer
-
批准号:7934596
-
项目类别:
-
资助金额:$50.0万
-
财政年份:2009
-
负责人:Paul Joseph Goodfellow
-
依托单位:
Administrative Core
-
批准号:7727353
-
项目类别:
-
资助金额:$5.54万
-
财政年份:2009
-
负责人:Paul Joseph Goodfellow
-
依托单位:
SPORE in Endometrial Cancer
-
批准号:7690978
-
项目类别:
-
资助金额:$70.0万
-
财政年份:2009
-
负责人:Paul Joseph Goodfellow
-
依托单位:
FGFR2 MUTATIONS IN INTERMEDIATE RISK ENDOMETRIAL CANCERS
-
批准号:7533018
-
项目类别:
-
资助金额:$30.97万
-
财政年份:2008
-
负责人:Paul Joseph Goodfellow
-
依托单位:
FGFR2 MUTATIONS IN INTERMEDIATE RISK ENDOMETRIAL CANCERS
-
批准号:7644524
-
项目类别:
-
资助金额:$11.13万
-
财政年份:2008
-
负责人:Paul Joseph Goodfellow
-
依托单位:
Cancer Genetics Program
-
批准号:6998145
-
项目类别:
-
资助金额:$1.99万
-
财政年份:2004
-
负责人:Paul Joseph Goodfellow
-
依托单位:
A Murine Model for Endometrial Tumorigenesis
-
批准号:7361353
-
项目类别:
-
资助金额:$26.77万
-
财政年份:2004
-
负责人:Paul Joseph Goodfellow
-
依托单位:
Core--Hereditary Cancer Facility
-
批准号:6998198
-
项目类别:
-
资助金额:$6.23万
-
财政年份:2004
-
负责人:Paul Joseph Goodfellow
-
依托单位:
A Murine Model for Endometrial Tumorigenesis
-
批准号:6734571
-
项目类别:
-
资助金额:$28.06万
-
财政年份:2004
-
负责人:Paul Joseph Goodfellow
-
依托单位:
A Murine Model for Endometrial Tumorigenesis
-
批准号:7035855
-
项目类别:
-
资助金额:$26.02万
-
财政年份:2004
-
负责人:Paul Joseph Goodfellow
-
依托单位:
A Murine Model for Endometrial Tumorigenesis
-
批准号:6882639
-
项目类别:
-
资助金额:$26.69万
-
财政年份:2004
-
负责人:Paul Joseph Goodfellow
-
依托单位:
A Murine Model for Endometrial Tumorigenesis
-
批准号:7218700
-
项目类别:
-
资助金额:$25.22万
-
财政年份:2004
-
负责人:Paul Joseph Goodfellow
-
依托单位:
rDNA Methylation and prognosis in Endometrial Cancers
-
批准号:6599901
-
项目类别:
-
资助金额:$15.3万
-
财政年份:2003
-
负责人:Paul Joseph Goodfellow
-
依托单位:
CLONING A UTERINE SEROUS CARCINOMA TUMOR SUPPRESSOR GENE
-
批准号:6173061
-
项目类别:
-
资助金额:$17.12万
-
财政年份:1998
-
负责人:Paul Joseph Goodfellow
-
依托单位:
CLONING A UTERINE SEROUS CARCINOMA TUMOR SUPPRESSOR GENE
-
批准号:2896434
-
项目类别:
-
资助金额:$17.06万
-
财政年份:1998
-
负责人:Paul Joseph Goodfellow
-
依托单位:
海外基金